Podcasts about ucsf memory

New research from UC San Francisco's Memory and Aging Center suggests that a decline in one region of the brain can cause other regions to “step in to help” – unlocking surprising capacities like deeper empathy or creativity. We talk to two UCSF doctors about why this has implications for any neurodegenerative disorder, including dementia. They join us to share their dementia-related discoveries. Their new book is “Mysteries of the Social Brain.” Guests: Dr. Bruce Miller, A.W. and Mary Margaret Clausen Distinguished Professor in Neurology, UCSF; Director of the UCSF Memory and Aging Center; founding director of the Global Brain Health Institute Dr. Virginia Sturm, professor in the Departments of Neurology and Psychiatry and Behavioral Sciences, UCSF Learn more about your ad choices. Visit megaphone.fm/adchoices

Top Psychologists John Gartner and Harry Segal are joined by Professor of Neuropsychology and Neurology at UCFF Dr. Joel Kramer, as they parse significant differences between Biden's chronic stutter and Trump's glaring dementia. Make sure you join us here on Patreon to support our work and gain access to exclusive perks: patreon.com/ReallyAmericanMedia Our site: https://cms.megaphone.fm/channel/shrinking-trump  Subscribe on iTunes: https://podcasts.apple.com/us/podcast/really-political/id1742461616 Subscribe on Spotify: https://open.spotify.com/show/6AEHmPMAqDlLJEbMgXq1iJ Subscribe on Amazon Music: https://music.amazon.com/podcasts/83ca7283-59fb-4cb7-a34b-03c4b0218f29 Subscribe on iHeartRadio: https://www.iheart.com/podcast/269-really-political-169545670/ Dr. Joel Kramer is the director of the neuropsychology program at the UCSF Memory and Aging Center. He studies the effects of neurodegenerative disease on intellectual abilities and behavior.  Dr. Kramer was quoted in the Washington Post last week saying that the risk for both Biden and Trump are “about the same for demonstrating some degree of cognitive decline over the next four to five years.” Our host John Gartner brought him on the show to challenge this conclusion. The Post failed to mention that in their interview Dr. Kramer also said, “Biden has an established history of a developmental language disorder - stuttering, while Trump's gaffes are more likely driven by disordered thinking.” Welcome to another addition of Shrinking Trump, our weekly show where we review the ways in which Trump's behavior over the past week demonstrates signs of early onset of dementia, and express his malignant personality disorder. “And each week,” Dr. Segal says, “we've been trying to help you, our listeners, as well as the media, to think about Trump in a more clinically sophisticated and accurate way.” We'll analyze Trump's wildest episodes from the past week and point out the different variables that likely influence his shifting behaviors and cognitive ability.  From forgetting the name of Joe Biden and the Doctor who administered his cognitive test, to calling Milwaukee a “horrible” city, to suggesting that Nancy Pelosi would want to date him, Trump “really writes his own Saturday Night Live cold open,” as Dr. Gartner puts it.  “Why are we talking about this? Because there's a deterioration in his frontal lobes that are causing him to become disinhibited and lose his executive functioning.” Clips on social media can be distorted and misleading. At times Trump can be articulate and forceful. But as our hosts show you each week, there is likely enough video evidence to diagnose actual signs of a progressive dementia and cognitive decline.  “As I predicted when we started this show two months ago, he will continue to get worse, Dr. Gartner said. “He will continue to show these symptoms more and more.”  Dr. Kramer answers Dr. Gartner's challenge, defend his statements, and will walk us through the major differences between Trump and Biden, as both a concerned citizen and as a practicing neuropsychologist.  “You and I are taking a big risk by coming on this show every week and talking, not definitively, but arguing strongly for a diagnosis of Trump,” Dr. Segal said.  “Not just what seems to me to be an onset of cognitive decline, but also his severe personality disorder. But the mainstream press doesn't want to come out and label Trump. And so they're just putting it out there that they're both old. I think it's cowardly. I don't think it helps the public.” Learn more about your ad choices. Visit megaphone.fm/adchoices

Mild Cognitive Impairment (MCI) is associated with early stages of neurodegenerative diseases like Alzheimer's and other dementias. Many people living with dementia cite symptoms of MCI as an early sign. Yet, there's lots of confusion with what might be “normal” memory loss that comes with aging or a sign to see a doctor. UCSF's Emily Paolillo, PhD, joins Being Patient Live Talks to explain MCI and what goes into diagnosis. As an Assistant Professor at the UCSF Memory and Aging Center, her clinical work includes providing neuropsychological evaluations to aid in diagnosis and treatment of patients with possible neurodegenerative diseases. In addition, her research focuses on evaluating digital health tools for early detection and monitoring of neurobehavioral changes in Alzheimer's disease, as well as understanding how lifestyle behaviors can grant risk and resilience to dementia. RSVP to this live talk to learn more about MCI and what to keep in mind about diagnosis. If you loved watching this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/ Follow Being Patient: Twitter:   / being_patient_   Instagram:   / beingpatientvoices   Facebook:   / beingpatientalzheimers   LinkedIn:   / being-patient   Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category...#Alzheimers #Dementia #MCI #BrainHealth

In this live panel at the UCSF Memory and Aging Center, Emily sits down with playwright Jake Broder, actor Lucy Davenport, and neurologist Bruce Miller to discuss Broder's play UnRavelled, which explores the fascinating relationship between dementia, art, and music. Find show notes, transcript, and more at thenocturnists.com.

The U.S. Food and Drug Administration is expected to approve the experimental dementia drug Lecanemab as soon as this week, a move embraced by Alzheimer's disease researchers after trials showed it slowed the progression of the disease in some patients with mild cognitive impairment. The new potential therapy is also raising hopes that it could help those who are symptom-free but have brain changes -- detected by new blood tests -- that signal Alzheimer's. We'll talk about the latest advances in Alzheimer's research. Guests: Dr. Adam Boxer, endowed professor in memory and aging and professor of neurology, UCSF - He directs UCSF's Neurosciences Clinical Research Unit and the Alzheimer's Disease and Frontotemporal Degeneration Clinical Trials Program at the UCSF Memory and Aging Center. Dr. Kristine Yaffe, professor of psychiatry, neurology and epidemiology, UCSF - She also directs UCSF's Center for Population Brain Health. Dr. Michael Weiner, professor of radiology, UCSF - principal investigator of the Alzheimer's Disease Neuroimaging Initiative Learn more about your ad choices. Visit megaphone.fm/adchoices

It's our last episode of our dementia research mini-series! And as a follow up to our recap of Day 4, we interviewed Dr. Adam Boxer to learn more about fluid biomarkers - AKA - we ask him all about what the bloodwork and lumbar puncture is used for. Stay tuned for a very special ending of our 8-part series. Thank you for coming on the journey with us and please let us know what you think of this series by reaching out to us on our website! www.remembermeftd.com Adam L. Boxer, MD, PhD, is Endowed Professor in Memory and Aging in the Department of Neurology at the University of California, San Francisco (UCSF). He directs UCSF's Neurosciences Clinical Research Unit and the Alzheimer's Disease and Frontotemporal Degeneration (FTD) Clinical Trials Program at the UCSF Memory and Aging Center. Dr. Boxer's research is focused on developing new treatments and biomarkers for neurodegenerative diseases, particularly those involving tau and TDP-43. Dr. Boxer received his medical and doctorate degrees as part of the NIH-funded Medical Scientist Training Program at New York University Medical Center. He completed an internship in Internal Medicine at California Pacific Medical Center, a residency in Neurology at Stanford University Medical Center, followed by a fellowship in behavioral neurology at UCSF. We loved Dr. Boxer! Enjoy the science side of our experience, you guys! -- Special thank you to the ALLFTD Study for their support in the creation of this series. You can support Remember Me by visiting our website www.remembermeftd.com where you can shop our merch, join re-members only or donate. You can follow us on instagram @remembermepodcast. ---- Today's sponsor is The Bluefield Project: The Bluefield Project to Cure FTD, is on a mission to support research to improve our understanding of a genetic form of Frontotemporal dementia, and to help find a cure for this devastating disease. So how can you help? If FTD runs in your family, participating in a Natural History Study, or in a therapeutic clinical trial, makes an enormous contribution. To learn more, please go to ftdregistry.org ---- Remember Me is a podcast created by two moms who became fast friends on Instagram while caregiving for their parents. It features stories of Frontotemporal Dementia (FTD) with a focus on remembering individuals for who they were before the disease. The stories shared are raw, real, and so full of love. We hope it inspires you to "accept the good." --- Support this podcast: https://anchor.fm/rememberme/support

Women respond differently to medications and treatments than men do, but most medical research focuses just on men. Two scientists, Dr. Jane Salmon, a professor and associate dean at Weill Cornell College of Medicine, and Dr. Fanny Elahi, a neurologist at the UCSF Memory and Aging Center, are doing groundbreaking work that will result in better health for everyone. Learn more about your ad-choices at https://news.iheart.com/podcast-advertisers

Being Patient spoke with Kailin Casaletto, a neuropsychologist and assistant professor at UCSF Memory and Aging Center, about her study on the effects of regular physical and mental activity on brain health, particularly among those with a predisposition to develop frontotemporal dementia. Find more of our Being Patient: Brain Talks series at: https://bit.ly/300AD5S

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Dr. Geroges Naasan explores the principal clinical syndromes of Alzheimer's Disease: memory, visual, language and frontal/executive. He also discusses neuropathology, genetic factors and modern biomarkers with colleagues from the UCSF Memory and Aging Center. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 34775]

Nurse Rona will be joined by Josh Kornbluth, who is currently engaged in a year-long residency as a scholar at the Global Brain Health Institute. He is spending time with people who have dementia, their caregivers, researchers, nurses, and social workers. They will be joined by Dr. Jennifer Yokoyama, an Assistant Professor at the UCSF Memory and Aging Center.  The post The Brain, Memory, and Dementia appeared first on KPFA.

Show #166 | Guests: Josh Kornbluth, writer, comedian, activist, and Dr. Bruce Miller, A.W. and Mary Margaret Clausen Distinguished Professorship in Neurology at the University of California, San Francisco | Show Summary: Dementia statistics are daunting. One in three seniors dies with Alzheimers or other dementia; every 66 seconds someone in the US develops the disease. Monologist Josh Kornbluth has immersed himself in this realm, and incorporates his experience in “Josh’s Brain Improvs”, a coproduction with The Marsh theater in San Francisco. Kornbluth bases his series of improvisations on his experiences working at the Memory and Aging Center at UCSF and Trinity College in Dublin, Ireland, and his work as an artist-in-residence and volunteer at the Zen Hospice Project in San Francisco. Josh Kornbluth has performed autobiographical one-man shows since 1987 — The San Francisco Chronicle declared, Kornbluth takes a world we ignore, or barely observe, and brings it into brilliant comic relief. Dr. Bruce Miller holds the A.W. and Mary Margaret Clausen Distinguished Professorship in Neurology at the University of California, San Francisco (UCSF). He directs the busy UCSF dementia center where patients in the San Francisco Bay Area and beyond receive comprehensive clinical evaluations. His goal is the delivery of model care to all of the patients who enter the clinical and research programs at the UCSF Memory and Aging Center (MAC). Dr. Miller is a behavioral neurologist focused on dementia with special interests in brain and behavior relationships as well as the genetic and molecular underpinnings of disease. His work in frontotemporal dementia (FTD) emphasizes both the behavioral and emotional deficits that characterize these patients, while simultaneously noting the visual creativity that can emerge in the setting of FTD. He is the principal investigator of the NIH-sponsored Alzheimer’s Disease Research Center (ADRC) and program project on FTD called Frontotemporal Dementia: Genes, Imaging and Emotions. He oversees a healthy aging program, which includes an artist in residence program. In addition, he helps lead two philanthropy-funded research consortia, the Tau Consortium and Consortium for Frontotemporal Research, focused on developing treatments for tau and progranulin disorders, respectively. Also, he is the Co-Director of the Global Brain Health Institute. Dr. Miller teaches extensively, runs the Behavioral Neurology Fellowship at UCSF, and oversees visits of more than 50 foreign scholars every year.

ANCDS Podcast Ep. 4 - Treatment of Aphasia in Persons with Primary Progressive Aphasia Maya is a speech-language pathologist by training. She did her master’s and doctoral work at the University of Arizona, in the lab of Dr. Pelagie Beeson. Subsequently, she completed postdoctoral training in the lab of Dr. Maria Luisa Gorno-Tempini at the UCSF Memory and Aging Center. She is currently an Assistant Professor in the Department of Communication Sciences and Disorders at the University of Texas, Austin, where she is the director of the Aphasia Research and Treatment Lab. She teaches courses on aphasia and related neurogenic communication disorders as well as the cognitive and neural bases of speech and language. Her research interests lie in the nature and treatment of aphasia and related neurogenic communication disorders, with a special focus on primary progressive aphasia. Aphasia Research and Treatment Lab https://moody.utexas.edu/aphasialab The Association for Frontotemporal Degeneration http://www.theaftd.org

In February of 2015 the Osher Marin JCC presented a solo exhibition of works by San Francisco watercolor artist and philanthropist, Chris Hellman. At the opening reception her daughter, Dr. Tricia Gibbs, spoke about her mother's paintings and the challenges of Alzheimer's after which Dr. Bruce Miller MD, Neurologist and Clinical Director of the UCSF Memory and Aging Center, presented on the relationships between art and the brain.

Monday, April 30, 2012 at 3:30 pm PST/6:30 pm EST Dr. Michael Geschwind is Associate Professor of Neurology and the Michael J. Homer Chair in Neurology. He received his MD and PhD in neuroscience through the National Institutes of Health-sponsored Medical Scientist Training Program at the Albert Einstein College of Medicine in New York. He completed his internship in internal medicine at the University of California, Los Angeles Medical Center, his neurology residency at the Johns Hopkins University School of Medicine in Baltimore and his fellowship in behavioral neurology at the UCSF Memory and Aging Center (MAC). He joined the Memory and Aging Center faculty in 2003 and is now an associate professor and holds the Michael J. Homer Chair in Neurology.  Dr. Geschwind's primary research interest is the assessment and treatment of rapidly progressive dementias, including prion diseases, such as Creutzfeldt-Jakob disease (CJD), autoimmune antibody-mediated dementias and encephalopathies.   He also has an active interest in movement disorders and cognition, including Progressive supranucelar palsy (PSP), corticobasal syndrome (CBS), and Huntington's disease (HD). He is an active member of the Huntington's Study Group.  Tune in for some interesting information. Visit his website: www.memory.ucsf.edu